Imbed Biosciences Launches SAM™ PainGuard™ with Lidocaine for Surgical, Burn, and Trauma Wound Care

 Imbed Biosciences Inc., a leader in advanced wound care technology,  announced the launch of SAM™ PainGuard™ with Lidocaine, ...

August 29, 2025 | Friday | News
Ascletis’ ASC30 Oral Tablet Shows 2.3–3.3x Greater Drug Exposure Than Orforglipron in U.S. Phase Ib Study

ASC30 oral once-daily tablet demonstrated approximately 2.3-fold to 3.3-fold greater drug exposure than orforglipron in a cross-trial comparison. -...

August 28, 2025 | Thursday | News
Wugen Secures $115 Million Financing to Advance Pivotal Trial of First-in-Class Allogeneic CAR-T Therapy

Financing led by Fidelity Management & Research Company with participation from RiverVest Venture Partners, Lightchain Capital, LYZZ Capital, Abingw...

August 28, 2025 | Thursday | News
Genentech Breaks Ground on $700M Manufacturing Site in North Carolina, Expanding U.S. Biotech Footprint

The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D – &ndas...

August 26, 2025 | Tuesday | News
BriaCell Secures $2.05 Million NCI Grant to Advance Bria-PROS+™ Immunotherapy in Metastatic Prostate Cancer

  US$2,054,651 non-dilutive grant from the US National Cancer Institute to complete manufacturing of Bria-Pros+TM clinical supply and support Phase...

August 26, 2025 | Tuesday | News
Innovent Biologics Receives FDA Clearance to Launch First Global Phase 3 Trial of IBI363 in IO-Resistant Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing and commercializing h...

August 25, 2025 | Monday | News
Cube Biotech’s NativeMP™ Technology Powers First-Ever DEL Screening of Membrane Proteins with X-Chem

Cube Biotech, a pioneer in membrane protein stabilization and purification, and X-Chem, the global leader in DNA-Encoded Library (DEL) technology and dat...

August 22, 2025 | Friday | News
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in EU Unified Patent Court Over Paxlovid™

-Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infectio...

August 21, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close